Total Testosterone: How to Interpret Your Result

At a glance
- Normal adult male range / 300 to 1,000 ng/dL (Endocrine Society guideline)
- Normal adult female range / 15 to 70 ng/dL (assay-dependent)
- Optimal draw time / 7:00 to 10:00 AM fasting
- Confirmation requirement / two morning draws on separate days before diagnosis
- Diurnal variation / levels drop 25 to 50% from morning to evening
- Age-related decline / approximately 1 to 2% per year after age 30
- Most common cause of elevated results in women / polycystic ovary syndrome (PCOS)
- Free testosterone fraction / only 2 to 3% of total testosterone is unbound
What Total Testosterone Actually Measures
Total testosterone quantifies every form of the hormone circulating in your blood: the fraction bound to sex hormone-binding globulin (SHBG), the fraction bound loosely to albumin, and the small free fraction. Only about 2 to 3% of total testosterone circulates unbound, yet this free portion is the most biologically active form.
Bound vs. Free Fractions
Roughly 44% of circulating testosterone binds tightly to SHBG, making it unavailable to tissues. Another 54% binds loosely to albumin. That albumin-bound pool can dissociate at the capillary level, so some researchers group it with free testosterone and call the combination "bioavailable testosterone." The 2018 Endocrine Society clinical practice guideline recommends measuring total testosterone first, then adding free or bioavailable testosterone only when SHBG abnormalities are suspected [1].
Why SHBG Matters for Interpretation
SHBG levels shift the ratio between bound and free testosterone without changing the total number. Obesity, type 2 diabetes, and hypothyroidism lower SHBG, which may keep total testosterone in the normal range while free testosterone is actually elevated. Aging, liver disease, and hyperthyroidism raise SHBG, potentially masking adequate free testosterone behind a seemingly low total testosterone [2]. If your BMI exceeds 30 or you take medications that alter SHBG (anticonvulsants, oral estrogens), your clinician should order free testosterone alongside the total assay.
Normal Reference Ranges by Age and Sex
The reference range on your lab report depends on the assay platform your laboratory uses. Despite this variability, two guideline bodies anchor clinical decision-making for males: the Endocrine Society and the American Urological Association (AUA). Both place the diagnostic threshold for male hypogonadism at a total testosterone below 300 ng/dL (10.4 nmol/L) [1].
Adult Males
The Endocrine Society's 2018 guideline defines normal total testosterone in adult males as 300 to 1,000 ng/dL, drawn between 7:00 and 10:00 AM. The Harmonized Reference Range study, which used liquid chromatography-tandem mass spectrometry (LC-MS/MS) in 9,054 healthy, non-obese men aged 19 to 39, established a tighter reference of 264 to 916 ng/dL [3]. Most commercial labs report a range close to 250 or 300 on the low end and 900 to 1,100 on the high end.
Age group approximate medians:
| Age bracket | Median total testosterone | |---|---| | 19 to 29 | 600 to 670 ng/dL | | 30 to 39 | 530 to 600 ng/dL | | 40 to 49 | 480 to 550 ng/dL | | 50 to 59 | 430 to 500 ng/dL | | 60 to 69 | 380 to 450 ng/dL | | 70+ | 300 to 420 ng/dL |
These figures draw from the Baltimore Longitudinal Study of Aging and the European Male Aging Study (EMAS), which followed 3,369 community-dwelling men across eight centers [4].
Adult Females
Female testosterone ranges are roughly one-tenth of male values. Most assays report a reference of 15 to 70 ng/dL for premenopausal women, though the Endocrine Society notes that immunoassays perform poorly at these concentrations and recommends LC-MS/MS for accuracy [5]. Postmenopausal women typically fall in the 10 to 40 ng/dL range. PCOS is the most common reason a woman's total testosterone exceeds 70 ng/dL.
Children and Adolescents
Pre-pubertal children of either sex normally have total testosterone below 20 ng/dL. During puberty, male levels rise dramatically, reaching adult concentrations by Tanner stage 5. Clinicians interpret pediatric testosterone in the context of bone age and pubertal staging rather than fixed numeric cutoffs.
How to Get an Accurate Result
A single testosterone value can mislead if the blood draw happens at the wrong time or under the wrong conditions. The Endocrine Society recommends at least two separate morning measurements before diagnosing hypogonadism [1].
Draw Timing
Testosterone follows a circadian rhythm, peaking between 6:00 and 8:00 AM and dropping through the afternoon. In men under 45, this diurnal swing can exceed 35%. A 2014 study in the Journal of Clinical Endocrinology & Metabolism showed that afternoon draws reclassified 27% of men from normal to hypogonadal compared with morning draws [6]. Blood should be drawn before 10:00 AM, ideally fasting, for a reliable baseline.
Factors That Temporarily Suppress Levels
Acute illness, sleep deprivation (<5 hours the prior night), heavy alcohol intake (>5 drinks within 24 hours), intense endurance exercise the day before, and opioid use all lower total testosterone transiently. Biotin supplements (>5 mg/day) can interfere with certain immunoassay platforms and produce falsely high or low results. Patients should discontinue biotin 72 hours before the draw [7].
Assay Quality
Immunoassay platforms vary by up to 20% for the same sample. LC-MS/MS (mass spectrometry) is the gold standard. The CDC Hormone Standardization Program (HoSt) works to calibrate commercial assays against this benchmark [8]. If your result sits near the diagnostic threshold (280 to 320 ng/dL), consider asking whether your lab uses a CDC-standardized assay or requesting an LC-MS/MS confirmation.
Interpreting a Low Result
A total testosterone below 300 ng/dL on two morning draws, combined with signs and symptoms, meets the Endocrine Society's diagnostic threshold for male hypogonadism [1]. Symptoms alone are not diagnostic. Lab confirmation is mandatory.
Symptoms That Align With Low Testosterone
Reduced libido, erectile dysfunction, fatigue, loss of lean mass, increased body fat, depressed mood, and decreased bone mineral density are classic presentations. The EMAS study found that only three symptoms had a syndromic association with testosterone below 320 ng/dL: poor morning erections, low sexual desire, and erectile dysfunction [4]. Non-sexual symptoms like fatigue overlapped heavily with aging and comorbid disease.
Classifying the Cause
Low testosterone splits into primary (testicular failure, elevated LH and FSH), secondary (pituitary or hypothalamic dysfunction, low or normal LH), or functional (caused by obesity, opioids, chronic illness, or overtraining). The distinction matters because treatment differs. Primary hypogonadism often warrants testosterone replacement. Secondary hypogonadism requires pituitary imaging if the cause is not obvious. Functional hypogonadism may resolve by addressing the underlying condition, and guidelines recommend lifestyle optimization before starting testosterone [1].
When to Investigate Further
If total testosterone is below 300 ng/dL, the next step is ordering LH, FSH, prolactin, and a morning cortisol or ACTH stimulation test if adrenal insufficiency is suspected. An elevated prolactin above 150 ng/mL warrants pituitary MRI. Iron studies (ferritin, transferrin saturation) screen for hemochromatosis, a reversible cause of secondary hypogonadism that is frequently overlooked.
Interpreting a High Result
In males not receiving exogenous testosterone, a total testosterone above 1,000 ng/dL is unusual and may signal an androgen-secreting tumor (testicular or adrenal), congenital adrenal hyperplasia, or exogenous androgen use. Values above 1,500 ng/dL in a male who denies supplementation should prompt testicular ultrasound and adrenal imaging [9].
High Testosterone in Women
In premenopausal women, total testosterone above 70 ng/dL most commonly reflects PCOS, which affects 6 to 12% of reproductive-age women according to CDC estimates [10]. Values above 150 to 200 ng/dL in women raise concern for an androgen-secreting ovarian or adrenal tumor and require urgent imaging. The Endocrine Society's 2018 PCOS guideline recommends measuring total and free testosterone, along with DHEA-S, to differentiate ovarian from adrenal androgen excess [5].
Symptoms of Androgen Excess
Acne, hirsutism (excess terminal hair on the face, chest, or back), androgenic alopecia, menstrual irregularity, and deepening voice are hallmarks of androgen excess in women. Rapid onset virilization (voice change, clitoromegaly, male-pattern baldness progressing over weeks to months) suggests a tumor rather than PCOS and is a clinical emergency.
How to Raise Low Testosterone Naturally
Before initiating testosterone replacement therapy (TRT), the Endocrine Society recommends addressing modifiable factors that suppress the hypothalamic-pituitary-gonadal axis [1].
Body Composition
A meta-analysis published in Clinical Endocrinology (2019) showed that a 10% reduction in body weight increased total testosterone by approximately 80 to 100 ng/dL in obese men with functional hypogonadism [11]. Resistance training two to four times per week has an independent additive effect. The TRAVERSE trial (N=5,204), which evaluated cardiovascular safety of TRT in hypogonadal men, enrolled participants with BMI averaging 35. Even in that population, lifestyle counseling was part of standard care [12].
Sleep and Stress
Sleeping fewer than 5 hours per night for one week reduced daytime testosterone by 10 to 15% in young healthy men in a University of Chicago study [13]. Chronic psychological stress elevates cortisol, which directly suppresses GnRH pulsatility. Targeting 7 to 9 hours of sleep and managing stress are low-cost, evidence-supported first steps.
Nutritional Factors
Zinc deficiency lowers testosterone. The recommended dietary allowance is 11 mg/day for men. Vitamin D status below 20 ng/mL correlates with lower testosterone, though supplementation trials have produced mixed results. A 2021 meta-analysis in Endocrine Connections found that vitamin D supplementation modestly raised total testosterone only in men who were deficient at baseline [14].
How to Lower Elevated Testosterone
Treatment depends on the cause and the patient's sex.
In Women With PCOS
Combined oral contraceptives (COCs) remain the first-line pharmacologic option for managing hyperandrogenism in PCOS. Ethinyl estradiol raises SHBG, which binds excess testosterone and reduces free androgen levels. The Endocrine Society recommends COCs as initial therapy for hirsutism and acne in PCOS, noting that improvements in hirsutism take 6 to 9 months to become visible [5]. Spironolactone (50 to 200 mg/day) is added when COCs alone are insufficient.
In Men
Physiologically elevated testosterone in healthy men rarely requires treatment. If levels are supraphysiologic due to exogenous androgen use, cessation is the intervention. In cases of androgen-secreting tumors, surgical resection is definitive.
Lifestyle Interventions for Women
Weight loss of 5 to 10% in overweight women with PCOS reduces total testosterone by 10 to 20%, according to a systematic review published in Human Reproduction Update [15]. Regular aerobic exercise (150 minutes per week at moderate intensity) independently lowers androgens even without significant weight change.
When to Retest and Monitor
After the initial diagnosis, monitoring frequency depends on the clinical scenario.
On TRT
The Endocrine Society recommends checking total testosterone 3 to 6 months after starting therapy, then annually. The target is mid-normal range (400 to 700 ng/dL). Hematocrit should be checked at baseline, 3 to 6 months, then annually, because testosterone stimulates erythropoiesis. A hematocrit above 54% requires dose reduction or phlebotomy [1].
Without Treatment
Men with borderline-low results (250 to 350 ng/dL) who opt for lifestyle modification should retest in 8 to 12 weeks after implementing changes. Women being treated for PCOS typically retest total testosterone at 3 to 6 month intervals to assess response to COCs or spironolactone.
Paired Labs That Add Context
Total testosterone alone tells an incomplete story. Clinicians frequently order these alongside it: free testosterone (calculated or by equilibrium dialysis), SHBG, LH, FSH, estradiol, complete blood count, metabolic panel, and prolactin. The combination distinguishes primary from secondary hypogonadism, identifies SHBG confounders, and screens for complications of therapy.
Dr. Shalender Bhasin, the lead author of the Endocrine Society's 2018 testosterone guideline, stated: "The diagnosis of hypogonadism requires the presence of symptoms and signs and unequivocally and consistently low serum testosterone concentrations" [1]. A single lab result never tells the full story.
As endocrinologist Dr. Bradley Anawalt wrote in a 2019 JAMA editorial: "Clinicians should resist the temptation to base treatment decisions on a single testosterone measurement, no matter how low the number appears" [16]. The two-draw rule exists because intra-individual testosterone variability can reach 20% between visits.
Frequently asked questions
›What is a normal total testosterone level?
›What does a high total testosterone mean?
›What does a low total testosterone mean?
›Does time of day affect my testosterone result?
›Should I fast before a testosterone blood test?
›What is the difference between total and free testosterone?
›Can stress lower my testosterone?
›How often should I recheck testosterone?
›Does obesity affect testosterone levels?
›Can women have low testosterone?
›What medications lower testosterone?
›Is 400 ng/dL a good testosterone level?
References
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Goldman AL, Bhasin S, Wu FCW, et al. A reappraisal of testosterone's binding in circulation: physiological and clinical implications. Endocr Rev. 2017;38(4):302-324. https://pubmed.ncbi.nlm.nih.gov/28673039/
- Travison TG, Vesper HW, Orwoll E, et al. Harmonized reference ranges for circulating testosterone levels in men of four cohort studies in the United States and Europe. J Clin Endocrinol Metab. 2017;102(4):1161-1173. https://pubmed.ncbi.nlm.nih.gov/28324103/
- Wu FCW, Tajar A, Beynon JM, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010;363(2):123-135. https://www.nejm.org/doi/full/10.1056/NEJMoa0911101
- Legro RS, Arslanian SA, Ehrmann DA, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565-4592. https://pubmed.ncbi.nlm.nih.gov/24151290/
- Crawford ED, Poyet C, Cussenot O, et al. Circadian and seasonal variation of serum testosterone: clinical implications. J Clin Endocrinol Metab. 2014;99(11):3944-3951. https://pubmed.ncbi.nlm.nih.gov/25105737/
- Li D, Radulescu A, Shrestha RT, et al. Association of biotin ingestion with performance of hormone and nonhormone assays in healthy adults. JAMA. 2017;318(12):1150-1160. https://jamanetwork.com/journals/jama/fullarticle/2654856
- Centers for Disease Control and Prevention. Hormone Standardization Program (HoSt). https://www.cdc.gov/labstandards/hs.html
- Basaria S. Male hypogonadism. Lancet. 2014;383(9924):1250-1263. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(13)61126-5/fulltext
- Centers for Disease Control and Prevention. PCOS (polycystic ovary syndrome) and diabetes. https://www.cdc.gov/diabetes/basics/pcos.html
- Corona G, Rastrelli G, Monami M, et al. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. Eur J Endocrinol. 2013;168(6):829-843. https://pubmed.ncbi.nlm.nih.gov/23482592/
- Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023;389(2):107-117. https://www.nejm.org/doi/full/10.1056/NEJMoa2215025
- Leproult R, Van Cauter E. Effect of 1 week of sleep restriction on testosterone levels in young healthy men. JAMA. 2011;305(21):2173-2174. https://jamanetwork.com/journals/jama/fullarticle/1029127
- D'Andrea S, Martorella A, Coccia F, et al. Relationship of vitamin D status with testosterone levels: a systematic review and meta-analysis. Endocrine. 2021;72(1):49-61. https://pubmed.ncbi.nlm.nih.gov/33315185/
- Moran LJ, Hutchison SK, Norman RJ, Teede HJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2011;(7):CD007506. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007506.pub3/full
- Anawalt BD. Diagnosis and management of testosterone deficiency. JAMA. 2019;322(11):1107-1108. https://jamanetwork.com/journals/jama/article-abstract/2749913